# An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

> **NCT01867762** · PHASE2 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 211 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** JNJ 49095397
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01867762
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09-09
- **Primary completion:** 2014-08-06
- **Final completion:** 2014-09-01
- **Target enrollment:** 211 (ACTUAL)
- **Last updated:** 2019-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01867762

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01867762, "An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01867762. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*